10-KPeriod: FY2005

COLGATE PALMOLIVE CO Annual Report, Year Ended Dec 31, 2005

Filed February 24, 2006For Securities:CL

Summary

Colgate-Palmolive Company's 2005 10-K filing highlights a company focused on global leadership in oral, personal, and home care, alongside its Pet Nutrition segment. The company demonstrated solid sales growth, driven by both volume and strategic pricing, with notable performance in Latin America and Europe. A significant ongoing initiative is the 2004 Restructuring Program, aimed at streamlining operations, reducing manufacturing facilities, and optimizing the workforce. While this program incurred charges in 2005, it is expected to yield substantial cost savings and support increased profitability by 2008. Colgate-Palmolive continues to invest in innovation and new product development, particularly in its higher-margin oral care business, and is actively managing its international operations and associated currency risks.

Key Highlights

  • 1Colgate-Palmolive operates globally with products in over 200 countries, focusing on Oral, Personal, and Home Care, and Pet Nutrition segments.
  • 2Worldwide net sales increased by 7.5% in 2005, driven by a 5.5% volume gain and a 0.5% increase in net selling prices, with a positive foreign exchange impact.
  • 3The company is executing a multi-year 2004 Restructuring Program involving facility rationalization, workforce reduction, and business process optimization, with estimated charges between $750-$900 million.
  • 4Research and Development spending increased to $246.3 million in 2005, supporting product innovation and technological advancement.
  • 5The company faces significant risks related to its extensive international operations, including currency fluctuations, political/economic instability, and regulatory changes.
  • 6Colgate-Palmolive actively repurchased its common stock, with 15.1 million shares bought back in 2005 for $796.2 million.
  • 7The company continues to prioritize higher-margin businesses, exemplified by the acquisition of GABA in 2004 and the divestiture of certain non-core laundry detergent brands in 2005.

Frequently Asked Questions

Colgate-Palmolive operates in two primary product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care segment is further managed geographically through four reportable operating segments: North America, Latin America, Europe, and Asia/Africa.

The 2004 Restructuring Program is a four-year initiative commenced in December 2004 to enhance global leadership in core businesses. It involves rationalizing approximately one-third of manufacturing facilities, closing certain warehouses, and reducing the workforce by about 12%. While it incurred pretax charges totaling between $750 and $900 million, it is projected to generate annual savings of $325-$400 million by 2008.

The company actively monitors its significant international operations, which account for approximately 74% of net sales. Risks such as foreign currency exchange rate fluctuations are managed through cost-containment measures, price increases, and currency hedging. Political and economic instability are mitigated by geographic diversity, while regulatory changes are monitored and addressed through compliance efforts.

Colgate-Palmolive invests significantly in research and development, with spending at $246.3 million in 2005. This investment supports the development of technologically sophisticated products across its business segments, aiming to meet evolving consumer needs and maintain a competitive edge through innovation.